The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells

Clathrin-Mediated Internalization Is Essential for Sustained EGFR Signaling but Dispensable for Degradation

Sara Sigismund, Elisabetta Argenzio, Daniela Tosoni et al. · Developmental Cell · 2008 · 665 citations · Full text

Signal Transduction, Signaling Pathway, Medicine +10

<b>Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin</b>

Cary D. Austin, Ann M. De Mazière, Paul I. Pisacane et al. · Molecular Biology of the Cell · 2004 · 486 citations · Full text

Pathology, Surface Erbb2, Cancer Biology +20

A novel putative receptor protein tyrosine kinase of the met family.

Christophe Ronsin, Françoise Muscatelli, Marie‐Geneviève Mattéi et al. · PubMed · 1993 · 321 citations

RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

Giovanni Gaudino, Antonia Follenzi, Luigi Naldini et al. · The EMBO Journal · 1994 · 307 citations · Full text

Signal Transduction, Signaling Pathway, Receptor Tyrosine Kinase +7

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy

Lilach M. Friedman, Ariel Rinon, Bilha Schechter et al. · Proceedings of the National Academy of Sciences · 2005 · 258 citations · Full text

Cancer Research, Cancer Immunosurveillance, Signal Transduction +15